Literature DB >> 29864491

Denosumab: AHFS 92:24.

Andrew Wilcock1, Sarah Charlesworth2, Claire Stark Toller2, Rahul Girish2, Mary Mihalyo2, Paul Howard2.   

Abstract

Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. Additional content is available on www.palliativedrugs.com. Country-specific books (Hospice and Palliative Care Formulary USA, and Palliative Care Formulary, British and Canadian editions) are also available and can be ordered from www.palliativedrugs.com. The series editors welcome feedback on the articles (hq@palliativedrugs.com).
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29864491     DOI： 10.1016/j.jpainsymman.2018.05.021

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


  3 in total

1.  The Effect of Denosumab on Bone Mass in Super Elderly Patients.

Authors:  Chaiho Jeong; Jeonghoon Ha
Journal:  J Bone Metab       Date:  2020-05-31

Review 2.  Bone Remodeling and the Role of TRAF3 in Osteoclastic Bone Resorption.

Authors:  Brendan F Boyce; Jinbo Li; Lianping Xing; Zhenqiang Yao
Journal:  Front Immunol       Date:  2018-09-28       Impact factor: 7.561

3.  Identification of potential specific biomarkers and key signaling pathways between osteogenic and adipogenic differentiation of hBMSCs for osteoporosis therapy.

Authors:  Jianjun Wu; Peian Cai; Zhenhui Lu; Zhi Zhang; Xixi He; Bikang Zhu; Li Zheng; Jinmin Zhao
Journal:  J Orthop Surg Res       Date:  2020-09-23       Impact factor: 2.359
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.